Target intelligence / Profile preview

Cholesterol-binding protein (CBP)

Target
CBP
Molecular classification
Transporter, Receptor, Enzyme, Other
01

Overview

Cholesterol-binding proteins (CBPs) represent a broad functional class of proteins that specifically interact with cholesterol to regulate its transport, intracellular distribution, and signaling. This category encompasses several distinct protein families, including the Niemann-Pick C (NPC) proteins, sterol carrier proteins (SCPs), oxysterol-binding proteins (OSBPs), and caveolins. For instance, NPC1 and NPC1L1 are critical for the movement of cholesterol across lysosomal and intestinal membranes, respectively, while proteins like CETP facilitate the exchange of lipids between lipoproteins in the plasma. Due to their central role in maintaining lipid homeostasis, these proteins are significant therapeutic targets for treating hypercholesterolemia and atherosclerosis. Drugs such as ezetimibe target specific members of this class to lower blood cholesterol levels, while various CETP inhibitors have been investigated for their potential to raise high-density lipoprotein (HDL) levels and reduce cardiovascular events.

Other names
Sterol-binding proteinCholesterol-interacting proteinLipid-binding proteinSterol carrier proteinOxysterol-binding protein
02

Mechanism of action

Inhibition of cholesterol absorption (NPC1L1), inhibition of cholesterol ester transfer (CETP), modulation of lysosomal cholesterol egress (NPC1), or direct binding and sequestration of cholesterol.

03

Biological functions

Lipid metabolismCholesterol transportSignal transductionMembrane organizationHomeostasis
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseMetabolic disorderNiemann-Pick diseaseCancer
05

Safety considerations

Off-target lipid disruptionCardiovascular safety risks (e.g., blood pressure elevation with certain CETP inhibitors)Potential for lysosomal storage dysfunction
06

Interacting drugs

Ezetimibe

5 more in the full profile.

07

Biomarkers

LDL-CHDL-CTotal cholesterolOxysterol levelsNPC1 protein levels

Beyond the preview

Go deeper on Cholesterol-binding protein (CBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholesterol-binding protein (CBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call